Description
Screening for occult cancer in patients with unprovoked venous thromboembolism: Belgian expert guidance
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Screening for occult cancer in patients with unprovoked venous thromboembolism: Belgian expert guidance
€3.03
Related products
-
Article: INTRODUCTION
€3.03 Add to cart -
Article: Highlights in respiratory oncology
€3.03 Add to cart -
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart
